Literature DB >> 8209072

Comparison of the effects on lung function of two methods of bronchodilator administration.

B Yuksel1, A Greenough.   

Abstract

The aim of this study was to assess if administration of bronchodilator via a metered dose inhaler (MDI), rather than by a nebulizer, avoided the early paradoxical deterioration in lung function but, resulted in equally effective late bronchodilation. Fifteen children were studied at a median postnatal age of 9 months (range 9-18), all had been born prematurely at a median gestational age of 27 weeks (range 23-31). Lung function was measured by plethysmography before and 10 min after normal saline and 5 and 15 min after salbutamol given via an MDI and a nebulizer in random order. At 5 min, compared to baseline values, airways resistance (RAW) deteriorated by 16% after nebulized salbutamol but improved by 3% following salbutamol by the MDI (P < 0.03). At 15 min RAW improved by 14% following nebulized salbutamol and 15% after salbutamol via the MDI, there was no significant difference in the magnitude of bronchodilation between the two methods of administration. Our results therefore suggest, that as the early paradoxical deterioration in lung function is usually avoided by administering salbutamol via an MDI, this should be the preferred method of administration.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8209072     DOI: 10.1016/s0954-6111(05)80351-8

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  3 in total

1.  Inhaled salbutamol for wheezy infants: a randomised controlled trial.

Authors:  R J Chavasse; Y Bastian-Lee; H Richter; T Hilliard; P Seddon
Journal:  Arch Dis Child       Date:  2000-05       Impact factor: 3.791

2.  Ethnic origin and lung function of infants born prematurely.

Authors:  B Yüksel; A Greenough
Journal:  Thorax       Date:  1995-07       Impact factor: 9.139

Review 3.  Pharmacotherapy in Bronchopulmonary Dysplasia: What Is the Evidence?

Authors:  Rishika P Sakaria; Ramasubbareddy Dhanireddy
Journal:  Front Pediatr       Date:  2022-03-09       Impact factor: 3.418

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.